Valeant Completes Acquisition of Synergetics USA

Valeant Pharmaceuticals International has completed its acquisition of Synergetics USA, a supplier of precision surgical devices.

Synergetics focuses on the fields of ophthalmology and neurosurgery, and its product lines include precision engineered, disposable and reusable devices, surgical equipment and procedural kits.

The purchase, announced in September, is valued at $192 million. — Michael Cipriano